Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Rhizen Pharmaceuticals AG

2 abstracts

Abstract
Efficacy and safety of tenalisib, a PI3K δ/γ and SIK3 inhibitor, in patients with locally advanced or metastatic breast cancer: Updated results from an on-going phase II study.
Org: LTD High Technology Hospital Med Center, Batumi, Georgia, LLC Caucasus Medical Center, Simon Khechinashvili University Hospital, Rhizen Pharmaceuticals AG,
Abstract
Safety, pharmacokinetics and anti-tumor activity of RP12146, a PARP1/2 inhibitor, in patients with locally advanced or metastatic solid tumors.
Org: Jagiellonian University Hospital, Kraków, Poland, Kraków University Hospital, Krakow, Poland, Polish Mother's Memorial Hospital - Research Institute,